<DOC>
	<DOCNO>NCT00696098</DOCNO>
	<brief_summary>Short chain fatty acid ( mainly butyrate , acetate , propionate ) produce large intestine bacterial fermentation undigested carbohydrate , dietary fibre . Butyrate important energy source intestinal epithelium pivotal role regulation epithelial cell proliferation differentiation , immune function mucosal protection . Non-digestible carbohydrate ( prebiotics ) increase concentration colonic butyrate , propose responsible beneficial effect . Furthermore , butyrate enema proven effective treatment active ulcerative colitis . In present study , direct effect butyrate inflammation parameter colonic defence mucosal integrity distal colon study 40 patient diarrhoea predominant IBS ( D-IBS ) 40 patient ulcerative colitis remission ( UCrem ) use rectal enema . These patient group choose low-grade inflammation large intestine , therefore use model study mechanistic effect butyrate . The design use study effect butyrate patient group double blind randomized placebo-controlled parallel design .</brief_summary>
	<brief_title>Effects Butyrate Colonic Health Patients With Diarrhoea Predominant IBS UC Remission</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Butyric Acid</mesh_term>
	<criteria>Clinical diagnosis UC Diarrhea predominant IBS Stable western diet Age 18 65 BMI 18 35 Written informed consent All enemas suppository 2 week prior study Use corticosteroid 1 month prior study Use antibiotic 3 month prior study Budesonide 2 week prior study Changes medication 1 month prior study Lactation , pregnancy planning pregnancy Previous intestinal surgery Clinically significant systemic disease Excessive drinking ( &gt; 20 alcoholic consumption per week ) Changes prebiotic and/or probiotic use 2 week prior study Previous radiotherapy chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>